.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Healthtrust
Novartis
Medtronic
Express Scripts
Baxter
AstraZeneca
Dow
Chubb

Generated: November 22, 2017

DrugPatentWatch Database Preview

AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

What is the patent landscape for Aminosyn Ii 4.25% M In Dextrose 10% In Plastic Container, and what generic Aminosyn Ii 4.25% M In Dextrose 10% In Plastic Container alternatives are available?

Aminosyn Ii 4.25% M In Dextrose 10% In Plastic Container is a drug marketed by Abbott and Hospira Inc and is included in two NDAs.

The generic ingredient in AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER is amino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrate. There are three hundred and forty-one drug master file entries for this compound. Additional details are available on the amino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrate profile page.

Summary for AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER
amino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrate
INJECTABLE;INJECTION019564-003Dec 16, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER
amino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrate
INJECTABLE;INJECTION019682-002Nov 1, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Harvard Business School
Argus Health
Express Scripts
Deloitte
Queensland Health
Mallinckrodt
Chubb
Citi
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot